Developing a new national MDMA policy: Results of a multi-decision multi-criterion decision analysis

BACKGROUND: Ecstasy (3,4-methylenedioxymethamphetamine (MDMA)) has a relatively low harm and low dependence liability but is scheduled on List I of the Dutch Opium Act (‘hard drugs’). Concerns surrounding increasing MDMA-related criminality coupled with the possibly inappropriate scheduling of MDMA...

Descripción completa

Detalles Bibliográficos
Autores principales: van Amsterdam, Jan, Peters, Gjalt-Jorn Ygram, Pennings, Ed, Blickman, Tom, Hollemans, Kaj, Breeksema, Joost J Jacobus, Ramaekers, Johannes G, Maris, Cees, van Bakkum, Floor, Nabben, Ton, Scholten, Willem, Reitsma, Tjibbe, Noijen, Judith, Koning, Raoul, van den Brink, Wim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155737/
https://www.ncbi.nlm.nih.gov/pubmed/33530825
http://dx.doi.org/10.1177/0269881120981380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155737/
https://www.ncbi.nlm.nih.gov/pubmed/33530825
http://dx.doi.org/10.1177/0269881120981380

Ejemplares similares